Integrating tuberculosis and noncommunicable diseases care in low- and middle-income countries (LMICs): A systematic review.

Chuan De Foo, Pami Shrestha, Leiting Wang, Qianmei Du, Alberto L García-Basteiro, Abu Saleh Abdullah, Helena Legido-Quigley
Author Information
  1. Chuan De Foo: Saw Swee Hock School of Public Health, National University of Singapore, Singapore. ORCID
  2. Pami Shrestha: Saw Swee Hock School of Public Health, National University of Singapore, Singapore. ORCID
  3. Leiting Wang: Global Health Program, Duke Kunshan University, Kunshan, Jiangsu, China. ORCID
  4. Qianmei Du: Global Health Program, Duke Kunshan University, Kunshan, Jiangsu, China. ORCID
  5. Alberto L García-Basteiro: ISGlobal, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain. ORCID
  6. Abu Saleh Abdullah: Global Health Program, Duke Kunshan University, Kunshan, Jiangsu, China.
  7. Helena Legido-Quigley: Saw Swee Hock School of Public Health, National University of Singapore, Singapore. ORCID

Abstract

BACKGROUND: Low- and middle-income countries (LMICs) are facing a combined affliction from both tuberculosis (TB) and noncommunicable diseases (NCDs), which threatens population health and further strains the already stressed health systems. Integrating services for TB and NCDs is advantageous in tackling this joint burden of diseases effectively. Therefore, this systematic review explores the mechanisms for service integration for TB and NCDs and elucidates the facilitators and barriers for implementing integrated service models in LMIC settings.
METHODS AND FINDINGS: A systematic search was conducted in the Cochrane Library, MEDLINE, Embase, PubMed, Bibliography of Asian Studies, and the Global Index Medicus from database inception to November 4, 2021. For our search strategy, the terms "tuberculosis" AND "NCDs" (and their synonyms) AND ("delivery of healthcare, integrated" OR a range of other terms representing integration) were used. Articles were included if they were descriptions or evaluations of a management or organisational change strategy made within LMICs, which aim to increase integration between TB and NCD management at the service delivery level. We performed a comparative analysis of key themes from these studies and organised the themes based on integration of service delivery options for TB and NCD services. Subsequently, these themes were used to reconfigure and update an existing framework for integration of TB and HIV services by Legido-Quigley and colleagues, which categorises the levels of integration according to types of services and location where services were offered. Additionally, we developed themes on the facilitators and barriers facing integrated service delivery models and mapped them to the World Health Organization's (WHO) health systems framework, which comprises the building blocks of service delivery, human resources, medical products, sustainable financing and social protection, information, and leadership and governance. A total of 22 articles published between 2011 and 2021 were used, out of which 13 were cross-sectional studies, 3 cohort studies, 1 case-control study, 1 prospective interventional study, and 4 were mixed methods studies. The studies were conducted in 15 LMICs in Asia, Africa, and the Americas. Our synthesised framework explicates the different levels of service integration of TB and NCD services. We categorised them into 3 levels with entry into the health system based on either TB or NCDs, with level 1 integration offering only testing services for either TB or NCDs, level 2 integration offering testing and referral services to linked care, and level 3 integration providing testing and treatment services at one location. Some facilitators of integrated service include improved accessibility to integrated services, motivated and engaged providers, and low to no cost for additional services for patients. A few barriers identified were poor public awareness of the diseases leading to poor uptake of services, lack of programmatic budget and resources, and additional stress on providers due to increased workload. The limitations include the dearth of data that explores the experiences of patients and providers and evaluates programme effectiveness.
CONCLUSIONS: Integration of TB and NCD services encourages the improvement of health service delivery across disease conditions and levels of care to address the combined burden of diseases in LMICs. This review not only offers recommendations for policy implementation and improvements for similar integrated programmes but also highlights the need for more high-quality TB-NCD research.

References

  1. Glob Public Health. 2018 Sep;13(9):1192-1203 [PMID: 28984493]
  2. Health Policy Plan. 2010 Mar;25(2):104-11 [PMID: 19917651]
  3. Cureus. 2016 Jan 13;8(1):e458 [PMID: 26918226]
  4. Lancet Diabetes Endocrinol. 2015 May;3(5):323-30 [PMID: 25754415]
  5. Lung India. 2017 Sep-Oct;34(5):468-469 [PMID: 28869235]
  6. Trop Med Int Health. 2017 Apr;22(4):505-511 [PMID: 28117937]
  7. Sci Rep. 2019 Aug 15;9(1):11901 [PMID: 31417132]
  8. Microbiol Spectr. 2016 Dec;4(6): [PMID: 28084206]
  9. BMC Med Res Methodol. 2016 Mar 15;16:32 [PMID: 26979282]
  10. BMC Public Health. 2020 Jun 1;20(1):822 [PMID: 32487173]
  11. BMC Health Serv Res. 2020 Jun 3;20(1):502 [PMID: 32493313]
  12. Int J Tuberc Lung Dis. 2018 Jan 1;22(1):86-92 [PMID: 29297431]
  13. Infect Dis Clin North Am. 1997 Jun;11(2):385-409 [PMID: 9187953]
  14. PLoS One. 2014 Jun 17;9(6):e99551 [PMID: 24937319]
  15. Lancet Psychiatry. 2018 Dec;5(12):952-954 [PMID: 30241700]
  16. Adv Respir Med. 2020;88(1):6-12 [PMID: 32153002]
  17. J Altern Complement Med. 2005 Feb;11(1):205-7 [PMID: 15750383]
  18. Int J Infect Dis. 2019 Dec;89:45-50 [PMID: 31449924]
  19. Int Health. 2017 Mar 1;9(2):100-104 [PMID: 28338880]
  20. Glob J Health Sci. 2015 Dec 18;8(8):54448 [PMID: 27045413]
  21. Infect Dis Poverty. 2012 Dec 24;1(1):13 [PMID: 23849044]
  22. PLoS One. 2020 Jul 9;15(7):e0235843 [PMID: 32645060]
  23. Science. 2012 Sep 21;337(6101):1499-501 [PMID: 22997329]
  24. PLoS One. 2012;7(10):e46988 [PMID: 23071690]
  25. Int J Environ Res Public Health. 2021 Mar 02;18(5): [PMID: 33801381]
  26. Trop Dis Travel Med Vaccines. 2015;1: [PMID: 26835156]
  27. Mil Med Res. 2020 Feb 29;7(1):7 [PMID: 32111253]
  28. BMC Med Res Methodol. 2014 Apr 01;14:45 [PMID: 24690082]
  29. BMC Psychiatry. 2019 Mar 1;19(1):82 [PMID: 30823918]
  30. BMC Health Serv Res. 2019 Jan 31;19(1):83 [PMID: 30704459]
  31. BMC Health Serv Res. 2018 Feb 21;18(1):132 [PMID: 29466980]
  32. Int J Tuberc Lung Dis. 2018 Nov 1;22(11):1258-1268 [PMID: 30355404]
  33. PLoS One. 2018 Aug 23;13(8):e0202256 [PMID: 30138331]
  34. Trop Med Health. 2021 Jul 13;49(1):57 [PMID: 34256862]
  35. BMJ Open. 2020 Oct 8;10(10):e036985 [PMID: 33033087]
  36. Health Policy Plan. 2018 Dec 1;33(10):1128-1143 [PMID: 30590543]
  37. PLoS One. 2013 Nov 13;8(11):e80017 [PMID: 24236170]
  38. Int J Nurs Stud. 2012 Jan;49(1):47-53 [PMID: 21835406]
  39. Prim Care Companion CNS Disord. 2015 Oct 22;17(5): [PMID: 26835164]
  40. Eur Respir J. 2011 May;37(5):1269-82 [PMID: 20947679]
  41. Int J Epidemiol. 2013 Feb;42(1):221-7 [PMID: 23064501]
  42. Eur Respir J. 2015 Apr;45(4):928-52 [PMID: 25792630]
  43. Lancet Infect Dis. 2013 May;13(5):436-48 [PMID: 23531392]
  44. Lancet Glob Health. 2016 Nov;4(11):e806-e815 [PMID: 27720688]
  45. Int J Drug Policy. 2007 Aug;18(4):306-12 [PMID: 17689379]
  46. Int J Clin Pharm. 2011 Feb;33(1):44-52 [PMID: 21365392]
  47. Braz J Psychiatry. 2019 Jul-Aug;41(4):316-323 [PMID: 30365672]
  48. Health Policy Plan. 2010 Jan;25(1):1-14 [PMID: 19959485]
  49. Trop Med Int Health. 2013 Feb;18(2):199-211 [PMID: 23217030]
  50. Lancet Infect Dis. 2011 Nov;11(11):855-67 [PMID: 22035614]
  51. J Acquir Immune Defic Syndr. 2012 Jun 1;60(2):e29-35 [PMID: 22395671]
  52. Health Policy Plan. 2012 Oct;27 Suppl 4:iv9-19 [PMID: 23014156]
  53. Cold Spring Harb Perspect Med. 2015 Apr 27;5(9):a017863 [PMID: 25918181]
  54. Perm J. 2018 Jul 19;22:17-176 [PMID: 30010536]
  55. Bull World Health Organ. 2011 May 1;89(5):352-9 [PMID: 21556303]
  56. Int J Tuberc Lung Dis. 2014 Feb;18(2):174-9 [PMID: 24429309]
  57. BMC Public Health. 2019 Jan 8;19(1):29 [PMID: 30621655]
  58. Iran J Public Health. 2015 Jan;44(1):1-11 [PMID: 26060770]
  59. Infect Drug Resist. 2019 Sep 30;12:3093-3102 [PMID: 31686870]
  60. PLoS One. 2018 Jul 26;13(7):e0201163 [PMID: 30048495]
  61. BMC Infect Dis. 2018 Oct 26;18(1):536 [PMID: 30367622]
  62. Cad Saude Publica. 2018 Feb 05;34(1):e00153116 [PMID: 29412320]
  63. BMJ Open. 2018 Apr 28;8(4):e021467 [PMID: 29705769]
  64. Lancet Glob Health. 2019 Apr;7(4):e448-e460 [PMID: 30819531]
  65. J Clin Tuberc Other Mycobact Dis. 2019 Aug;16:100112 [PMID: 31497655]
  66. Res Rep Trop Med. 2019 Mar 01;10:1-10 [PMID: 30881174]
  67. PLoS One. 2013;8(3):e57791 [PMID: 23469242]
  68. World Psychiatry. 2009 Feb;8(1):40-4 [PMID: 19293959]
  69. Health Syst Reform. 2015 May 19;1(4):250-256 [PMID: 31519094]
  70. Am J Public Health. 2011 Apr;101(4):654-62 [PMID: 21330583]
  71. Diabetes Metab Syndr Obes. 2021 Feb 04;14:515-523 [PMID: 33568928]
  72. Syst Rev. 2020 Oct 6;9(1):228 [PMID: 33023668]
  73. Med Access Point Care. 2021 Apr 27;5:23992026211011314 [PMID: 36204497]
  74. Health Policy Plan. 2017 Nov 1;32(suppl_4):iv13-iv26 [PMID: 28666336]
  75. Glob Public Health. 2019 Sep;14(9):1372-1381 [PMID: 30785858]
  76. Cochrane Database Syst Rev. 2011 Jul 06;(7):CD003318 [PMID: 21735392]
  77. BMJ. 2019 Jan 28;364:l251 [PMID: 30692093]
  78. Int J Tuberc Lung Dis. 2015 Jul;19(7):787-91 [PMID: 26056102]

MeSH Term

Developing Countries
Humans
Noncommunicable Diseases
Tuberculosis

Word Cloud

Created with Highcharts 10.0.0servicesTBintegrationserviceLMICsdiseasesNCDshealthintegrateddeliverystudiesNCDlevelthemeslevelssystematicreviewfacilitatorsbarriersANDusedframework31testingcareprovidersmiddle-incomecountriesfacingcombinedtuberculosisnoncommunicablesystemsIntegratingburdenexploresmodelssearchconducted42021strategytermsmanagementbasedlocationresourcesstudyeitherofferingincludeadditionalpatientspoorBACKGROUND:Low-afflictionthreatenspopulationstrainsalreadystressedadvantageoustacklingjointeffectivelyThereforemechanismselucidatesimplementingLMICsettingsMETHODSFINDINGS:CochraneLibraryMEDLINEEmbasePubMedBibliographyAsianStudiesGlobalIndexMedicusdatabaseinceptionNovember"tuberculosis""NCDs"synonyms"deliveryhealthcareintegrated"ORrangerepresentingArticlesincludeddescriptionsevaluationsorganisationalchangemadewithinaimincreaseperformedcomparativeanalysiskeyorganisedoptionsSubsequentlyreconfigureupdateexistingHIVLegido-QuigleycolleaguescategorisesaccordingtypesofferedAdditionallydevelopedmappedWorldHealthOrganization'sWHOcomprisesbuildingblockshumanmedicalproductssustainablefinancingsocialprotectioninformationleadershipgovernancetotal22articlespublished201113cross-sectionalcohortcase-controlprospectiveinterventionalmixedmethods15AsiaAfricaAmericassynthesisedexplicatesdifferentcategorisedentrysystem2referrallinkedprovidingtreatmentoneimprovedaccessibilitymotivatedengagedlowcostidentifiedpublicawarenessleadinguptakelackprogrammaticbudgetstressdueincreasedworkloadlimitationsdearthdataexperiencesevaluatesprogrammeeffectivenessCONCLUSIONS:Integrationencouragesimprovementacrossdiseaseconditionsaddressoffersrecommendationspolicyimplementationimprovementssimilarprogrammesalsohighlightsneedhigh-qualityTB-NCDresearchlow-:

Similar Articles

Cited By